Mesa Laboratories (MLAB) News Today $98.59 -1.16 (-1.16%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Mesa Laboratories (NASDAQ:MLAB) Lowered to Hold Rating by StockNews.comNovember 17, 2024 | americanbankingnews.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Royce & Associates LPRoyce & Associates LP reduced its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 12.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 347,145 shares of the medical instruments supplier's stoNovember 15, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Stock Rating Lowered by StockNews.comStockNews.com lowered shares of Mesa Laboratories from a "buy" rating to a "hold" rating in a research report on Wednesday.November 13, 2024 | marketbeat.comMesa Labs price target lowered to $150 from $160 at Evercore ISINovember 13, 2024 | markets.businessinsider.comMesa Laboratories Reports Robust Q2 FY25 ResultsNovember 9, 2024 | markets.businessinsider.comMesa Labs Announces Second Quarter ResultsNovember 7, 2024 | globenewswire.comStockNews.com Upgrades Mesa Laboratories (NASDAQ:MLAB) to "Buy"StockNews.com raised shares of Mesa Laboratories from a "hold" rating to a "buy" rating in a research note on Tuesday.November 5, 2024 | marketbeat.comRice Hall James & Associates LLC Has $2.87 Million Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Rice Hall James & Associates LLC lifted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 44.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,108 shares of the medical instrumentsNovember 2, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Conestoga Capital Advisors LLCConestoga Capital Advisors LLC reduced its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 7.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 529,110 shares of the medical instruments suppliNovember 1, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) CEO Gary M. Owens Sells 2,518 SharesOctober 30, 2024 | insidertrades.comInsider Selling: Mesa Laboratories, Inc. (NASDAQ:MLAB) CEO Sells 2,518 Shares of StockMesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) CEO Gary M. Owens sold 2,518 shares of Mesa Laboratories stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $113.62, for a total value of $286,095.16. Following the sale, the chief executive officer now directly owns 45,888 shares in the company, valued at $5,213,794.56. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.October 29, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Rating Increased to Buy at StockNews.comStockNews.com raised shares of Mesa Laboratories from a "hold" rating to a "buy" rating in a research note on Saturday.October 26, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Stock Price Down 7.4% - What's Next?Mesa Laboratories (NASDAQ:MLAB) Shares Down 7.4% - Time to Sell?October 23, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Cut to Hold at StockNews.comStockNews.com lowered Mesa Laboratories from a "buy" rating to a "hold" rating in a research report on Friday.October 18, 2024 | marketbeat.comAnalysis of Chuck Royce's Recent Transaction in Mesa Laboratories IncOctober 16, 2024 | finance.yahoo.comRenaissance Technologies LLC Reduces Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Renaissance Technologies LLC trimmed its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 85.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,400 shares of the medical instruments supplier'October 13, 2024 | marketbeat.comMarshall Wace LLP Lowers Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Marshall Wace LLP trimmed its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 44.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 14,560 shares of the medical instruments supplier'sOctober 7, 2024 | marketbeat.comMackenzie Financial Corp Buys New Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Mackenzie Financial Corp purchased a new position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 6,867 shares of the medical instruments supplier's stock, valued atOctober 6, 2024 | marketbeat.comPoint72 Asset Management L.P. Has $680,000 Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Point72 Asset Management L.P. cut its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 62.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,841 shares of the medical instruments suppOctober 5, 2024 | marketbeat.comMESA LABS DECLARES QUARTERLY DIVIDENDOctober 2, 2024 | globenewswire.comMeros Investment Management LP Buys Shares of 28,299 Mesa Laboratories, Inc. (NASDAQ:MLAB)Meros Investment Management LP purchased a new position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 28,299 shares of the medical instrumentSeptember 27, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by King Luther Capital Management CorpKing Luther Capital Management Corp lessened its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 28.3% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,921 shares of the medical instruments suppSeptember 22, 2024 | marketbeat.comAlbuquerque City Council approves $1 million in funding for Mesa Film Studios ProjectSeptember 19, 2024 | msn.comMesa Laboratories, Inc. (NASDAQ:MLAB) SVP Sells $187,375.00 in StockSeptember 17, 2024 | insidertrades.comIs Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 30% Discount?September 14, 2024 | finance.yahoo.comMesa Laboratories appoints Moss Adams as new auditorSeptember 13, 2024 | uk.investing.comWells Fargo Initiates Coverage of Mesa Laboratories (MLAB) with Underweight RecommendationAugust 30, 2024 | msn.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Acquired by Raymond James & AssociatesRaymond James & Associates boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 8.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 80,739 shares of the medical instruments supAugust 28, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Research Coverage Started at Wells Fargo & CompanyWells Fargo & Company began coverage on Mesa Laboratories in a report on Tuesday. They set an "underweight" rating and a $120.00 price objective on the stock.August 27, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Shares Gap Up to $128.90Mesa Laboratories (NASDAQ:MLAB) Shares Gap Up to $128.90August 23, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Shares Gap Down to $130.82Mesa Laboratories (NASDAQ:MLAB) Shares Gap Down to $130.82August 20, 2024 | marketbeat.comI:RUT Aug 2024 Weekly 2235.000 (RUTW240819P02235000)August 19, 2024 | finance.yahoo.comMesa Laboratories (NASDAQ:MLAB) Stock Price Down 2.3%Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 2.3%August 16, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Stock Price Passes Above Two Hundred Day Moving Average of $104.59Mesa Laboratories (NASDAQ:MLAB) Shares Pass Above Two Hundred Day Moving Average of $104.59August 16, 2024 | marketbeat.comMesa County announces limited COVID-19 vaccine suppliesAugust 15, 2024 | msn.comEvercore ISI Increases Mesa Laboratories (NASDAQ:MLAB) Price Target to $120.00Evercore ISI increased their target price on shares of Mesa Laboratories from $106.00 to $120.00 and gave the company an "outperform" rating in a research report on Tuesday.August 6, 2024 | marketbeat.comMesa Laboratories, Inc.: Mesa Labs Announces First Quarter ResultsAugust 5, 2024 | finanznachrichten.deMesa Labs Announces First Quarter ResultsAugust 5, 2024 | globenewswire.comMotley Fool Asset Management LLC Boosts Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Motley Fool Asset Management LLC boosted its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 89.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,488 shares of the medical instruments sJuly 31, 2024 | marketbeat.comAndvari Sold One of its Longest Holdings Mesa Laboratories (MLAB) in Q2July 31, 2024 | msn.comWhat Does Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Share Price Indicate?July 29, 2024 | finance.yahoo.comMesa Laboratories, Inc. Plans Quarterly Dividend of $0.16 (NASDAQ:MLAB)Mesa Laboratories, Inc. (NASDAQ:MLAB) announced a quarterly dividend on Tuesday, July 9th. Investors of record on Friday, August 30th will be paid a dividend of 0.16 per share by the medical instruments supplier on Monday, September 16th. This represents a $0.64 annualized dividend and a yield of 0.69%. The ex-dividend date is Friday, August 30th.July 9, 2024 | marketbeat.comMESA LABS DECLARES QUARTERLY DIVIDENDJuly 8, 2024 | globenewswire.comMesa Laboratories (NASDAQ:MLAB) PT Lowered to $106.00 at Evercore ISIEvercore ISI lowered their target price on Mesa Laboratories from $120.00 to $106.00 and set an "outperform" rating on the stock in a research report on Tuesday.July 2, 2024 | marketbeat.comBoone Capital Management LLC Buys New Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)Boone Capital Management LLC bought a new stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 64,064 shares of the medical instruments supplier's stock, valued at approximately $6,712,000. MesaJune 13, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Stock Price Down 5%Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 5%June 10, 2024 | marketbeat.comMLAB Stock Earnings: Mesa Laboratories Beats EPS, Beats Revenue for Q4 2024June 5, 2024 | investorplace.comMesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 ResultsJune 5, 2024 | globenewswire.comMesa Laboratories (NASDAQ:MLAB) Stock Price Up 3.9%Mesa Laboratories (NASDAQ:MLAB) Trading 3.9% HigherJune 4, 2024 | marketbeat.comPrincipal Financial Group Inc. Cuts Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)Principal Financial Group Inc. lessened its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 81.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,828 shares of the medical instrumenJune 1, 2024 | marketbeat.com Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. MLAB Media Mentions By Week MLAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MLAB News Sentiment▼0.310.45▲Average Medical News Sentiment MLAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MLAB Articles This Week▼22▲MLAB Articles Average Week Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DAKT News FARO News VPG News COHR News CGNX News BMI News ITRI News OSIS News SENS News HURC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MLAB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MLAB Stock Alerts